Expanded Histologic Lineage and Origin of Mesonephric-Like Adenocarcinoma: A Clinicopathologic Study of 9 Cases

Shi Y, Yuxiang Shi, Lyu X, Xiaojuan Lyu, Zheng J, Jing Zheng, Luo B, Bo Luo, Li Li, Li L, Bin Li, Li B, Li R, Ruiting Li, Hongfeng Zhang, Zhang H
International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists · 2026 · vol. 45(3) , pp. 200–209 · doi:10.1097/PGP.0000000000001154 · PMID:41744277
other OA: closed public-domain-us
Full text JSON View on PubMed View at publisher
⚙ AI-generated summary by claude@2026-08, 2026-08-01 ⓘ

This study analyzed 9 mesonephric-like adenocarcinoma cases, revealing atypical locations and molecular findings that expand the known spectrum of this tumor and support a Müllerian epithelial origin.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

⚙ AI-generated deep summary by claude@2026-06, 2026-06-23 · read from full text ⓘ

This retrospective clinicopathologic study examined 9 cases of mesonephric-like adenocarcinoma (MLA) using histology, immunohistochemistry, and next-generation sequencing to address controversy about whether MLA arises from mesonephric or Müllerian ducts. The authors observed unusual anatomic distributions including ovarian MLA coexisting with a benign mucinous cystadenoma, MLA on the cervical mucosal surface, and a mesenteric MLA component intermixed with clear cell carcinoma; they also report endometriosis around tumor tissue and in an adjacent ovary in one case. Sequencing identified KRAS mutations in 5 of 7 cases, with additional mutations in PTEN/BRAF and ERBB3 (1 each). This study is relevant to endometriosis/adenomyosis because endometriosis or adenomyosis was detected in 3 of the 9 cases, including peritumoral endometriosis in the mesenteric/clear cell mixed case, though the paper’s main focus is MLA lineage and origin.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

Mesonephric-like adenocarcinoma (MLA) is a rare gynecologic malignancy primarily arising in the uterine corpus and ovaries. It shares remarkable similarities in its histomorphology, immunophenotype, and molecular features with mesonephric adenocarcinoma of the cervix. Controversy remains regarding whether the MLA originates from the mesonephric or Müllerian ducts. In this study, we retrospectively analyzed the clinicopathologic, immunohistochemical, and molecular characteristics of 9 MLA cases. Among these, we observed 2 unique cases for the first time: 1 case of ovarian MLA coexisting with a benign mucinous cystadenoma and 1 case of MLA located on the cervical mucosal surface. In addition, 1 case presented with a mesenteric MLA component intermixed with clear cell carcinoma, and endometriosis was detected around the cancerous tissue and in the adjacent ovary. Of the remaining 6 cases, 3 were associated with endometriosis or adenomyosis. Next-generation sequencing of 7 cases revealed KRAS mutations in 5 cases and mutations in PTEN/BRAF and ERBB3 in 1 case each. The identification of MLA in atypical locations such as the mesentery and cervical mucosa expands the histologic spectrum of this tumor and provides further support for the hypothesis of a Müllerian epithelial origin. The findings of this study broaden the known morphologic and anatomic distribution of MLA and contribute to a better understanding of its pathogenesis.
Full text 2,232 characters · extracted from oa-doi-fallback · click to expand
Mesonephric-like adenocarcinoma (MLA) is a rare gynecologic malignancy primarily arising in the uterine corpus and ovaries. It shares remarkable similarities in its histomorphology, immunophenotype, and molecular features with mesonephric adenocarcinoma of the cervix. Controversy remains regarding whether the MLA originates from the mesonephric or Müllerian ducts. In this study, we retrospectively analyzed the clinicopathologic, immunohistochemical, and molecular characteristics of 9 MLA cases. Among these, we observed 2 unique cases for the first time: 1 case of ovarian MLA coexisting with a benign mucinous cystadenoma and 1 case of MLA located on the cervical mucosal surface. In addition, 1 case presented with a mesenteric MLA component intermixed with clear cell carcinoma, and endometriosis was detected around the cancerous tissue and in the adjacent ovary. Of the remaining 6 cases, 3 were associated with endometriosis or adenomyosis. Next-generation sequencing of 7 cases revealed KRAS mutations in 5 cases and mutations in PTEN/BRAF and ERBB3 in 1 case each. The identification of MLA in atypical locations such as the mesentery and cervical mucosa expands the histologic spectrum of this tumor and provides further support for the hypothesis of a Müllerian epithelial origin. The findings of this study broaden the known morphologic and anatomic distribution of MLA and contribute to a better understanding of its pathogenesis. Expanded Histologic Lineage and Origin of Mesonephric-Like Adenocarcinoma: A Clinicopathologic Study of 9 Cases Plain Language SummaryMesonephric-like adenocarcinoma (MLA) is a rare cancer found in the uterus and ovaries, similar to cervical mesonephric adenocarcinoma. This study analyzed 9 MLA cases, revealing unique occurrences: one in the ovary with a benign cyst, another on the cervical surface, and one in the mesentery mixed with clear cell carcinoma and surrounded by endometriosis. Genetic testing showed KRAS mutations in 5 cases, and other mutations in PTEN/BRAF and ERBB3. These findings suggest MLA may originate from Müllerian ducts, expanding its known locations and aiding in understanding its development. Text is machine generated and may contain inaccuracies. FAQ

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

⚙ Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback ⓘ

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

endometriosisadenomyosis

MeSH descriptors

Adenocarcinoma Adenocarcinoma Adenocarcinoma Adenocarcinoma Adenocarcinoma Adenocarcinoma Adenocarcinoma Adenocarcinoma Adenocarcinoma Adenocarcinoma Adenocarcinoma Adenocarcinoma Adenocarcinoma Adenocarcinoma Adenocarcinoma Adenocarcinoma Adenocarcinoma Adenocarcinoma Adenocarcinoma Adenocarcinoma

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2026) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

europepmc
last seen: 2026-08-08T06:08:32.324769+00:00
pubmed
last seen: 2026-08-08T06:04:25.227066+00:00
unpaywall
last seen: 2026-05-11T08:34:28.763810+00:00
License: public-domain-us · commercial use OK · attribution required
Courtesy of the U.S. National Library of Medicine